Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7000
+0.0217 (3.20%)
At close: Jun 6, 2025, 4:00 PM
0.6999
-0.0001 (-0.01%)
After-hours: Jun 6, 2025, 7:31 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $36.25 million as of June 6, 2025. Its market cap has decreased by -18.17% in one year.
Market Cap
36.25M
Enterprise Value
-44.96M
1-Year Change
-18.17%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $36.25M, a decrease of -91.51%. That is a compound annual growth rate of -49.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 36.25M | -16.98% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.19B |
| Johnson & Johnson | 369.26B |
| AbbVie | 330.67B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 268.18B |
| Abbott Laboratories | 232.58B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |